Diagnostics
This could be the first step in a long journey that could amount to huge profitability for the iPhone maker.
Boston Business Journal pulled together a list of the 25 biggest gainers in the state for 2017, and five of them are biopharma companies.
In the wake of sexual harassment allegations, OrbiMed Advisors’ founder and managing partner Sam Isaly has stepped down from his position.
Freenome, headquartered in South San Francisco, is focused on developing a diagnostic test for early detection of cancer and other diseases on the so-called “liquid biopsy,” in other words, blood.
A new application for its Apple Watch could save thousands of lives.
LifeOmic is planning to build new headquarters at the Indiana University Emerging Technology Center.
The addition of Pellini means the San Diego-based firm launched earlier this year can increase its investing pace and tap his healthcare experience as an executive at Foundation.
Apostle, headquartered in Sunnyvale, Calif., hopes to file an IPO or establish other strong business collaborative routes in five years.
BioSpace is proud to present its NextGen “Class of 2018,” a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.
There’s been a major shakeup in the executive team at Human Longevity.
PRESS RELEASES